Letter-to-the-editor: Ethical concerns over stem cell research
By Osagie Obasogie,
Los Angeles Times
| 08. 29. 2006
The recent breakthrough that may allow scientists to create human embryonic stem cells without destroying embryos may move stem cell conversations beyond the deliberative quagmire of abortion politics and embryos' moral status. But it would be misguided to think that whether or not an embryo is destroyed marks the only ethical or social concern. Stem cell research may lead to therapies for devastating diseases. But will designer medicines premised on stem cell research be affordable to anyone other than the wealthy, particularly after California's taxpayers invested nearly $6 billion in their development? How will researchers obtain the eggs necessary to pursue this research, and how will this affect women's health? How can we oversee these technologies and their applications while ensuring that a growing industry with the keys to life's building blocks acts in the public's interest?
How embryos are treated with regard to stem cell research is unquestionably important. But equally important is how we treat each other.
Related Articles
By Katie LaGrone, WPTV | 06.28.2024
Image by National Cancer Institute from Unsplash
TAMPA, Fla. — A Tampa jury recently found the now-defunct Lung Institute in Tampa guilty of engaging in “deceptive or unfair practices” while it offered customers “valueless” stem cell therapy to treat incurable...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...
By David Jensen [cites CGS' Pete Shanks], The California Stem Cell Report | 06.24.2024
Image by NIH Image Gallery from Flickr
The Biopolitical Times reported this month that the California stem cell and gene therapy program “seems to be in serious trouble.”
“On first glance, it may look impressive, with over a thousand patients...